Award

Multi-Modal MRI to Assess Alzheimer's Disease Prevention in an APOE4 MouseModel

Description: Narrative The proposed research is relevant to public health because we will use multi-modal MRI as surrogate markers to assess efficacy of Rapamycin for restoring brain vascular, metabolic, and structural functions in mice that carry APOE4 genes, the strongest genetic risk factor for Alzheimer's disease (AD). Because MRI methods are readily able to be used in humans and Rapamycin is FDA-approved, the findings from the study will provide valuable information, and may pave a way, for future Rapamycin clinical trials to prevent AD for pre- symptomatic APOE4 carriers.
Funding type: research
Funder scheme: R01
Start date: 2017-07-01
End date: 2025-04-30
Investigator: AI-LING LIN (lead)
Institutions: University of Missouri, UNIVERSITY OF MISSOURI-COLUMBIA
Funded outputs count: 31
Funder award ID: R01AG054459
OpenAlex ID: G6936018654
2024 · Basavaraju G Sanganahalli, Jelena M Mihailovic, et al. · Journal of Cerebral Blood Flow & Metabolism · 14
2022 · Tyler C. Hammond, Sarah Messmer, et al. · Frontiers in Stroke · 14
2022 · Lucille M. Yanckello, Brian Fanelli, et al. · Journal of Cellular Immunology · 23
2022 · Tyler C. Hammond, Ai-Ling Lin · Journal of Cellular Immunology · 29
2021 · Tyler C. Hammond, Xin Xing, et al. · Journal of Cellular Immunology · 26
2021 · Gongbo Liang, Xin Xing, et al. · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · 46
2021 · Qi Ying, Xin Xing, et al. · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · 35
2020 · Xin Xing, Gongbo Liang, et al. · Lecture notes in computer science · 65
2020 · Ai-Ling Lin, Ishita Parikh, et al. · Neurobiology of Disease · 50
2019 · Candice E. Van Skike, Ai‐Ling Lin, et al. · Aging Cell · 86
2019 · Lucille M. Yanckello, Lyndsay E. A. Young, et al. · Frontiers in Nutrition · 13
2018 · Danielle N. Lyons, Hemendra Vekaria, et al. · Journal of Neurotrauma · 63